文献速递传染病防控与疫情报告卫生政策与健康促进

2012至2020年扬州市利福平耐药肺结核流行特征及治疗转归分析

[Analysis of the epidemic characteristics and treatment outcomes of rifampicin-resistant pulmonary tuberculosis in Yangzhou City from 2012 to 2020].
PubMed 文献 · Zhonghua Yu Fang Yi Xue Za Zhi · 2024-01-01

基于中国疾病预防控制信息系统2012—2020年扬州市利福平耐药肺结核(RR-PTB)患者资料,采用χ2检验分析流行特征、logistic回归分析治疗转归相关因素。年均登记发病率0.57/10万,复治患者占比64.8%高于初治35.2%,男性、≥60岁、复治和宝应县居民为防控重点人群。

要点

  • 2012—2020年扬州市RR-PTB年均登记发病率为0.57/10万。
  • 复治患者占比64.8%,高于初治患者的35.2%。
  • 年龄≥60岁和复治分类为影响成功治疗的危险因素。

核心结论

  • 扬州市RR-PTB疫情防控的重点人群为男性、≥60岁人群、复治患者和宝应县地区居民。
  • 年龄≥60岁和复治分类为影响RR-PTB患者成功治疗的危险因素(P<0.05)。

研究设计与样本

  • 从中国疾病预防控制信息系统中获取2012—2020年扬州市RR-PTB患者病例资料。
  • 采用χ2检验分析RR-PTB患者流行特征,采用logistic回归分析治疗转归相关因素。

主要发现

  • 2012—2020年扬州市RR-PTB患者年均登记发病率为0.57/10万,各年份登记发病率差异有统计学意义(χ2=29.326,P<0.001)。
  • 复治患者占比64.8%高于初治患者35.2%(χ2=50.593,P<0.001)。
  • 男性登记发病率0.91/10万高于女性0.24/10万(χ2=80.566,P<0.001)。
  • 年龄≥60岁年龄段登记发病率最高(0.96/10万),0~<45岁年龄段最低(0.31/10万,χ2=55.853,P<0.001)。
  • 2012—2020年宝应县RR-PTB患者登记数44例最多,登记发病率0.64/10万仅次于广陵区0.98/10万;宝应县2016—2020年较2012—2015年登记发病率显著增加(P=0.001)。

关键数值与推荐

  • 年龄≥60岁和复治分类为影响RR-PTB患者成功治疗的危险因素(P<0.05)。

临床怎么用

  • 扬州市RR-PTB疫情防控应以男性、≥60岁人群、复治患者和宝应县地区居民为重点人群。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Information on patients with rifampicin-resistant pulmonary tuberculosis (RR-PTB) in Yangzhou City from 2012 to 2020 was obtained from the Information System of the Chinese Center for Disease Control and Prevention. The epidemic characteristics of RR-PTB patients were analyzed by using χ2 test. The average annual registered incidence rate of RR-PTB patients in Yangzhou City from 2012 to 2020 was 0.57/100 000, and the difference between the registered incidence rates in each year was statistically significant (χ2=29.326, P<0.001). The proportion of re-treated patients (64.8%) was higher than that of newly treated patients (35.2%, χ2=50.593, P<0.001). The registered incidence rate in males (0.91/100 000) was higher than that in females (0.24/100 000, χ2=80.566, P<0.001). The age distribution showed that the highest incidence rate was in the age group≥60 years (0.96/100 000) and the lowest was in the age group 0-<45 years (0.31/100 000, χ2=55.853, P<0.001). From 2012 to 2020, Baoying County had the largest number of registered RR-PTB patients (44 cases), and its registered incidence rate (0.64/100 000) was only lower than that of Guangling District (0.98/100 000). The registered incidence rate of RR-PTB patients in Baoying County during 2016-2020 also increased significantly compared to 2012-2015 (P=0.001). Logistic regression was used to analyze the factors related to the treatment outcome of RR-PTB patients. The results showed that patients aged≥60 years and those classified as the re-treatment were risk factors for successful treatment of RR-PTB patients (P<0.05). In summary, males, people aged≥60 years, patients classified as the re-treatment, and residents of Baoying County should be the key populations for RR-PTB epidemic prevention and control in Yangzhou City. 从中国疾病预防控制信息系统中获取2012—2020年扬州市利福平耐药肺结核(RR-PTB)患者病例资料,采用χ2检验分析RR-PTB患者流行特征,结果显示,2012—2020年扬州市RR-PTB患者年均登记发病率0.57/10万,各年份登记发病率差异有统计学意义(χ2=29.326,P<0.001),复治患者占比(64.8%)高于初治患者(35.2%,χ2=50.593,P<0.001)。男性登记发病率(0.91/10万)高于女性(0.24/10万,χ2=80.566,P<0.001)。年龄分布显示,患者登记发病率以≥60岁年龄段最高(0.96/10万),0~<45岁年龄段最低(0.31/10万,χ2=55.853,P<0.001)。2012—2020年宝应县RR-PTB患者登记数(44例)最多,登记发病率(0.64/10万)仅次于广陵区(0.98/10万),而2016—2020年与2012—2015年相比,宝应县RR-PTB患者登记发病率亦显著增加(P=0.001)。采用logistic回归分析RR-PTB患者的治疗转归相关因素,结果显示,患者年龄≥60岁和复治分类为影响RR-PTB患者成功治疗的危险因素(P<0.05)。综上,扬州市RR-PTB疫情防控的重点人群为男性、≥60岁人群、复治患者和宝应县地区的居民。.

来源:Zhonghua Yu Fang Yi Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Wang H, Li JC, Bo CG, et al. [Analysis of the epidemic characteristics and treatment outcomes of rifampicin-resistant pulmonary tuberculosis in Yangzhou City from 2012 to 2020]. Zhonghua Yu Fang Yi Xue Za Zhi. 2024. PMID: 39537405. doi:10.3760/cma.j.cn112150-20240102-00003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。